Multi-Center Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients with Moderate to Severe Respiratory Distress
Brief description of study
The purpose of this study is to investigate whether hyperbaric oxygen therapy is an effective way to treat hypoxemia (low blood oxygen levels) in patients who have tested positive for COVID-19 or have a clear clinical diagnosis of COVID-19 and have high supplemental oxygen requirements. In this study, all patients will receive the usual standard care to treat hypoxemia. Some patients will receive the study’s hyperbaric oxygen therapy in addition to standard of care.
Clinical Study Identifier: s20-00897
ClinicalTrials.gov Identifier: NCT04619719
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
